Posterior minimal extrathyroidal extension as an independent risk factor for lateral lymph node metastasis in papillary thyroid carcinoma: a retrospective study based on a nomogram prediction model - Report - MDSpire

Posterior minimal extrathyroidal extension as an independent risk factor for lateral lymph node metastasis in papillary thyroid carcinoma: a retrospective study based on a nomogram prediction model

  • By

  • Qi Zhao

  • Tong Li

  • Haochang Gu

  • Bin Lv

  • Nan Liu

  • June 17, 2026

  • 0 min

Share

Clinical Report: The Role of Posterior Minimal Extrathyroidal Extension in PTC

Overview

This study investigates the impact of posterior minimal extrathyroidal extension (post-mETE) on lateral lymph node metastasis (LLNM) in papillary thyroid carcinoma (PTC).

Background

Papillary thyroid carcinoma (PTC) is the most common type of thyroid cancer, with a significant incidence of lymph node metastasis that affects patient outcomes. This study examines the distinct effects of post-mETE compared to anterior minimal extrathyroidal extension (ant-mETE) on LLNM.

Data Highlights

ParameterValue
Patients with LLNM391 (21.75%)
OR for post-mETE2.036
AUC of nomogram0.850

Key Findings

  • Post-mETE is significantly associated with a higher incidence of LLNM compared to ant-mETE (p<0.001).
  • Six independent predictive factors for LLNM were identified: maximum tumor diameter >1 cm, bilateral thyroid involvement, multifocality, number of central lymph node metastases ≥2, tumor located at the upper pole, and post-mETE.
  • The nomogram developed showed good discrimination performance with an AUC of 0.850.
  • Occult lateral lymph node metastasis (OLLNM) is a significant cause of postoperative recurrence.

Clinical Implications

The findings suggest that post-mETE should be considered a significant risk factor for LLNM in PTC patients. The predictive nomogram can assist clinicians in identifying patients at high risk for LLNM, potentially guiding decisions regarding adjuvant therapy and follow-up management.

Conclusion

Post-mETE is a critical factor in predicting LLNM in PTC patients. The developed nomogram provides a valuable tool for enhancing perioperative management strategies.

Related Resources & Content

  1. Frontiers in Endocrinology, 2026 -- A nomogram as a predictive tool for lymph node metastasis in papillary thyroid carcinoma
  2. Frontiers in Endocrinology, 2026 -- Clinicopathological landscape and management trends of thyroid carcinoma over two decades
  3. The Journal of Clinical Endocrinology & Metabolism, 2025 -- Utilizing Machine Learning for Predicting Lateral Lymph Node Metastasis in cN0 Papillary Thyroid Carcinoma
  4. 2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer
  5. aace endocrine ai — Model predicts thyroid cancer in hard-to-reach lymph nodes
  6. NCCN Guidelines® Insights: Thyroid Carcinoma, Version 1.2025
  7. 2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer - Matthew D. Ringel, Julie Ann Sosa, Zubair Baloch, Lindsay Bischoff, Gary Bloom, Gregory A. Brent, Pamela L. Brock, Roger Chou, Robert R. Flavell, Whitney Goldner, Elizabeth G. Grubbs, Megan Haymart, Steven M. Larson, Angela M. Leung, Joseph Osborne, John A. Ridge, Bruce Robinson, David L. Steward, Ralph P. Tufano, Lori J. Wirth, 2025
  8. Associations of clinicopathologic features and mutation status with lateral lymph node metastasis as a predictor of disease-free survival in papillary thyroid carcinoma - PubMed

Original Source(s)

Related Content